Re-imagining CRISPR Technology for Use with Primary Immune Cells: New Insights for Cell-Based Immunotherapy Research

Webinar: Re-imagining CRISPR Technology for Use with Primary Immune Cells: New Insights for Cell-Based Immunotherapy Research

In this webinar, Dr. Shifrut presents a novel pooled CRISPR screening technology with the potential to prioritize novel targets for cancer immunotherapy drug development and to improve the design of genetically reprogrammed cell-based therapies.

StemCell Technologies Inc. and affiliates ("STEMCELL Technologies") does not share your email address with third parties. StemCell Technologies Inc. will use your email address to confirm your identity and send you newsletters, transaction-related emails, promotional and customer service emails in accordance with our privacy policy. You can change your email preferences at any time.